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Abstract
Motivation: In recent years, Mendelian randomization analysis using summary data
from genome-wide association studies has become a popular approach for investigating
causal relationships in epidemiology. The mrrobust Stata package implements several of
the recently developed methods.
Implementation: mrrobust is freely available as a Stata package.
General features: The package includes inverse variance weighted estimation, as well as
a range of median, modal and MR-Egger estimation methods. Using mrrobust, plots can
be constructed visualizing each estimate either individually or simultaneously. The pack-
age also provides statistics such as I2GX , which are useful in assessing attenuation bias in
causal estimates.
Availability: The software is freely available from GitHub [https://raw.github.com/remlap
mot/mrrobust/master/].
Key words: Summary MR, MR-Egger, IVW, weighted median, Mendelian randomization, Stata
Key Messages
• The mrrobust software package facilitates two-sample summary MR analyses using summary data from genome-
wide association studies.
• The package allows for implementation of a range of summary MR estimators using Stata, improving the extent to
which results are reproducible.
• Conclusions from the supported analyses can be robust to sources of confounding bias and pleiotropy, though find-
ings should be considered with respect to the underlying assumptions of each estimator.
VC The Author(s) 2018. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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Introduction
Mendelian randomization1 has developed into a popular
approach to examining causal relationships in epidemiol-
ogy.2,3 By employing genetic variants as instrumental varia-
bles (IVs) it is possible to limit bias from confounding,
provided variants satisfy the assumptions of IV analysis.1,4
For a genetic variant to serve as a suitable instrument, three
assumptions must hold: (i) it must be associated with the
exposure of interest; (ii) there must be no confounders of
the instrument and outcome; and (iii) the instrument must
not affect the outcome except via the exposure of interest.5
Candidate variants are usually identified through large
genome-wide association studies (GWASs).6 However, IV
analyses using single variants rarely have sufficient power to
test hypotheses of interest.6,7 One approach to increase the
statistical power of Mendelian randomization studies is to
use multiple genetic variants as instruments within a two-
sample summary framework.8,9 Two-sample Mendelian
randomization estimates the effect of the exposure using
instrument-exposure and instrument-outcome associations
from different samples, often through methods originally
developed for meta-analysis.8,9 This is particularly useful as
MR estimators, such as MR Egger and median based regres-
sion, are robust to certain forms of violation of the third in-
strumental variable assumption.8,10,11 Violations of this
assumption can occur through directional pleiotropy, where
a genetic variant affects the study outcome through path-
ways that are not mediated via the exposure. Such develop-
ments have contributed to the increasing popularity of two-
sample summary MR.5
This paper introduces the mrrobust Stata package as a
tool to help researchers implement two-sample MR analy-
ses, and can be viewed as the Stata counterpart to toolkits
such as the MR-Base web application, and the
MendelianRandomization and TwoSampleMR R pack-
ages.12,13 Whereas it is possible to conduct individual-level
IV analyses in Stata using modules such as IVREG2,14 two-
sample summary MR has previously required bespoke code
to implement. The mrrobust package addresses this limita-
tion, providing a suite of popular two-sample MR methods
and sensitivity analyses. Before continuing, we briefly out-
line the three primary estimation methods included in the
mrrobust package, using the notation of Bowden et al.10,15
Methods
Inverse variance weighting (IVW)
To perform IVW, a weighted average b^IVW is calculated
using the set of ratio estimates b^J for each individual var-
iant J ¼ 1; 2; . . . ; j:9 Ratio estimates are obtained for each
variant by dividing the instrument-outcome association by
the corresponding instrument-exposure association. Such
association estimates are obtained by fitting simple linear
regression models of the outcome and exposure upon the
genetic variant, primarily by conducting a GWAS. Let c^j
and r2Yj denote the instrument-outcome association and
variance, respectively, for the jth variant. The IVW esti-
mate is then defined as:
b^IVW ¼
PJ
j¼1 wjb^jPJ
j¼1 wj
; wj ¼
c^2j
r2Yj
This corresponds to the estimate one would obtain from
a weighted linear regression of the set of instrument-
outcome associations upon the set of instrument-exposure
associations, constraining the intercept at the origin.9 One
drawback of the IVW approach is that causal effect
estimates can be biased in cases where one or more var-
iants exhibit directional pleiotropy.9
MR-Egger regression
MR-Egger regression is valid under weaker assumptions
than IVW, as it can provide unbiased causal effect esti-
mates even if the variants have pleiotropic effects. In this
case, the set of instrument-outcome associations is
regressed upon the set of instrument-exposure associations,
weighting the regression using precision of the instrument-
outcome associations, as in the IVW case.8 However, MR-
Egger does not constrain the intercept at the origin, and
the intercept represents an estimate of the average direc-
tional pleiotropic effect across the set of variants. The slope
of the model provides an unbiased estimate of the causal
effect.8,10 If there is little evidence of systematic differences
between the IVW and MR-Egger, then the IVW should be
preferred. The IVW is more efficient, but potentially less
robust, and in such cases the IVW estimate is often the
most appropriate estimate to adopt due to the greater pre-
cision of IVW estimates in comparison with other
approaches.10 If there are differences between the IVW and
MR-Egger estimates, this may be due to pleiotropy or to
heterogeneous treatment effects.
The utility of MR Egger regression hinges upon two
core assumptions. First, the INstrument Strength
Independent of Direct Effect (InSIDE) assumption requires
the effects of single nucleotide polymorphisms (SNPs) on
the exposure and their pleiotropic effects on the outcome
to be independent. If the InSIDE assumption holds, esti-
mates for variants with stronger instrument-exposure
associations ðc^jÞ will be closer to the true causal effect pa-
rameter than variants with weaker associations.8 Second,
the NO Measurement Error (NOME) assumption requires
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no measurement error to be present in the instrument-
exposure associations, and therefore that the variance of
the instrument-exposure association r2Xj ¼ 0. In cases
where NOME is strictly satisfied, estimates c^j will be equal
to cj and the variance of the ratio estimate for each var-
iant j is var b^j
 
¼ r
2
Yj
c^2j
. We further note that the NOME as-
sumption applies to other two-sample MR approaches and
is not therefore a unique feature of the MR Egger
approach.
In cases where the NOME assumption is violated, indi-
vidual variants will suffer from weak instrument bias, lead-
ing to attenuation of MR Egger estimates towards the null.
This can occur if the SNPs were not genome-wide signifi-
cant (p ¼ 5 108) or were selected from small GWAS.
One novel approach to assessing the strength of the
NOME assumption is to evaluate the I2GX statistic, inter-
preted as the relative degree of attenuation bias in the MR
Egger regression in the interval (0, 1).10 Thus, for example,
an I2GX value of 0.7 represents an estimated relative bias of
30% towards the null. Further details regarding calcula-
tion of the I2GX statistic are presented in the Supplementary
material, available at IJE online.
Weighted median
The weighted median approach is an adaptation of the
simple median estimator for two-sample summary MR.15
For a total number of variants J ¼ 2kþ 1, the simple me-
dian approach selects the middle ratio estimate b^kþ1, from
ordered ratio estimates b^1; b^2; . . . b^j:
15 In cases where the
total number of variants is even, the median is interpolated
as 12 b^k þ b^kþ1
 
. As the simple median approach is ineffi-
cient, particularly in cases with variable precision in the set
of ratio estimates, it is preferable to incorporate weights in
a fashion similar to the IVW and MR Egger approaches.
Let sj ¼
Pj
k¼1 wk be the sum of weights for the set of var-
iants 1; 2; . . . j, standardized so the sum of weights sJ¼1.
The weighted median estimator is the median of a distribu-
tion having estimate b^j as its pj ¼ 100 sj  wj2
 th
percen-
tile.15 For the range of percentile values, we perform a
linear extrapolation between neighbouring ratio estimates.
An important assumption of the median summary MR
approaches is that more than 50% of the genetic variants
do not exhibit directional pleiotropy. In the simple median
case, this threshold refers to the number of variants, where-
as in the weighted median case, the 50% threshold is with
respect to the weights of the non-pleiotropic variants.15
Additional estimators
As two-sample MR represents a developing area of genetic
epidemiology, novel approaches to causal effect estimation
are incorporated into the mrrobust package through fre-
quent updates. One such method is the mode-based estima-
tor put forward by Hartwig et al.16 Details on the
implementation of this approach with accompanying
examples can be found in the Supplementary material,
available at IJE online.
Visualizing MR estimates
One useful approach to presenting the results of MR analy-
ses is to produce a scatterplot, with the x and y axes repre-
senting the instrument-exposure and instrument-outcome
associations, respectively, for each variant. If one were to
draw a hypothetical regression line leading from the origin
to each variant, the slope of the line would represent a ra-
tio estimate of the causal effect using the single variant as
an instrument, that is dividing the instrument-outcome as-
sociation by the instrument-exposure association (defined
as bj above). The precision of the instrument-outcome as-
sociation estimate for each variant is illustrated using verti-
cal error bars, whereas horizontal error bars pertaining to
the instrument-exposure association may be omitted for
clarity. As the IVW, MR-Egger, median and modal
approaches essentially meta-analyse the set of ratio esti-
mates, it is possible to include regression lines highlighting
effect estimates of each approach for comparison. For such
regression lines, positive and negative slopes are indicative
of a positive or negative effect, respectively, whereas a
slope of zero represents the absence of an observed
association.
Implementation
The mrrobust package uses functions from moremata,17
addplot18 and the heterogi19 command. For versions of
Stata 13 and higher, it can be installed using the .net install
command from [https://raw.github.com/remlapmot/mrro
bust/master/]. For older versions of Stata, a zip archive of
the files is freely available for download at: [https://github.
com/remlapmot/mrrobust].
The package facilitates two-sample summary MR anal-
yses with key features including:
• IVW and MR-Egger regression approaches, including
fixed effects MR-Egger regression, standard error
correction and weighting options;
• unweighted, weighted and penalized weighted median
IV estimators, providing pleiotropy robust estimates in
cases where fewer than 50% of the genetic instruments
are valid;
• modal estimation following Hartwig et al.,16 including
weighted and unweighted variations;
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• presentation of heterogeneity statistics, statistics such as
I2GX for use in assessing attenuation bias,
10 and
Simulation Extrapolation (SIMEX) correction following
Bowden et al;10
• plotting tools to visualize IVW, MR-Egger and weighted
median estimators, as well as density plotting with re-
spect to implementing the modal estimator;
• and illustrative examples and documentation using data
from Do et al.20
Applied examples: adiposity and height as
predictors of serum glucose levels
To illustrate key features of the mrrobust package, we per-
form two analyses investigating potential relationships be-
tween adiposity, height and serum glucose. Adiposity was
selected owing to the vast body of evidence supporting a
positive association with serum glucose levels,21–24 where-
as height was based upon limited evidence of associa-
tion.25–27 Glucose was selected as an outcome with respect
to its hypothesized role in the development of type 2 diabe-
tes.21,27 Datasets were obtained from the MR-Base web
application and pruned for linkage disequilibrium before
conducting the analyses.13
Applied example I: adiposity and serum glucose
Though the relationship between adiposity and glucose has
received much attention in the literature, such studies are
predominantly observational and therefore may be subject
to bias from confounding. This provides motivation for
considering Mendelian randomization techniques which
are able to control for such unobserved confounding. In
the initial analysis, we select adiposity as an exposure mea-
sured using standardized body mass index (BMI), obtain-
ing estimates of its associations with genotypes and their
respective standard errors from Locke et al.28
For the outcome, we consider log transformed measures
of serum glucose logðmMÞ using effect estimates and stan-
dard errors from Shin et al.29 The summary data used for
this analysis are provided in the Supplementary material,
available at IJE online. Adopting a GWAS significance P-
value threshold of 5 108; a total of 79 independent
SNPs were identified in both samples. We confirmed the
linkage equilibrium (LD) between the SNPs using a clump-
ing algorithm, a clumping distance of 10000 kb and an LD
R2 of 0.001. This resulted in a total of 79 SNPs for use as
instrumental variables, details of which are presented in
the Supplementary material, available at IJE online.
Using mrrobust, we conducted IVW, MR-Egger and
weighted median regression approaches using the above
summary data. The code for our analysis is in the
Supplementary material, available at IJE online. For IVW
and MR Egger approaches, the regression was weighted us-
ing the variance of the instrument-outcome association. The
set of summary MR estimates are presented in Table 1A.
We find strong evidence of a positive association be-
tween BMI and serum glucose, using both IVW and
weighted median methods. Considering the MR Egger
case, a substantial average directional pleiotropic effect
was not detected, and the lack of significance with respect
to the effect estimate can be attributed to a lack of statisti-
cal power. An I2GX value of 0.88 was reported, which can
be interpreted as a relative bias in the MR-Egger estimate
of 12% towards the null. The estimates are shown in
Figure 1A, constructed using the mreggerplot command
which generates a scatterplot of the instrument-exposure
and instrument-outcome associations for each variant.
This shows the set of estimates to be in agreement, with
the plot being constructed as previously described.
Applied example II: height and serum glucose
As a further example, we consider the effect of
standardized height (metres) upon serum glucose, using
summary data from Wood et al.30 and outcome summary
data on log transformed serum glucose from Shin et al.29
The summary data used for this analysis are provided in
the Supplementary material, available at IJE online. We as-
sess the SNPS for LD using criteria from the previous ex-
ample and identify 367 SNPs as suitable instruments for
the analysis, details of which are presented in the
Table 1. Summary MR estimates for the effect of standard-
ized BMI (A) and height (B) upon log transformed serum
glucose
Estimate SE P-value 95% CI
BMI (A)
IVW
Effect 0.023 0.008 0.004 0.01, 0.04
MR Egger
Intercept 0.000 0.001 0.948 0.001, 0.001
Effect 0.022 0.022 0.325 0.02, 0.07
Weighted median
Effect 0.034 0.012 0.005 0.01, 0.06
Height (B)
IVW
Effect 0.002 0.003 0.641 0.005, 0.008
MR Egger
Intercept 0.0001 0.0003 0.627 0.0001, 0.0001
Effect 0.003 0.009 0.777 0.02, 0.02
Weighted median
Effect <0.0001 0.005 >0.99 0.01, 0.01
SE, standard error.
4 International Journal of Epidemiology, 2018, Vol. 00, No. 00
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/advance-article-abstract/doi/10.1093/ije/dyy195/5096673 by U
niversity Library user on 12 M
arch 2019
Supplementary material as above. The set of summary MR
estimates are presented in Table 1B.
From Table 1B, we find no evidence against the null hy-
pothesis of no association between height and serum glu-
cose levels using IVW, weighted median and MR Egger
regression. Considering the MR Egger case, there appeared
to be no evidence of directional pleiotropy, with an I2GX
value of 0.90 indicating a relative bias of 10% towards the
null. As in the previous example, a plot of the MR esti-
mates can be generated using the mreggerplot command as
shown in Figure 1B. In this scenario, the estimates appear
in agreement, indicating a lack of evidence for a substantial
directional pleiotropic effect.
Discussion
The mrrobust package is a freely available Stata package,
containing a number of summary MR estimation methods
which can be used to estimate causal effects. In the applied
example, the mrrobust package was able to provide a series
of estimates, finding evidence of a positive association be-
tween BMI and serum glucose and no evidence of associa-
tion between height and serum glucose. One possible
conclusion that can be drawn from these results is that pre-
viously reported associations between height and glucose
are driven by confounding factors.31,32 It is important,
however, to consider the extent to which Mendelian ran-
domization is appropriate for a given analysis and, by ex-
tension, situations in which mrrobust is suitable.
In the first instance, Mendelian randomization studies
only produce unbiased estimates when genetic instruments
satisfy the assumptions of each estimator (e.g. IVW, MR-
Egger or weighted median). In two-sample analyses, genetic
instruments should be associated with the exposure of inter-
est at genome-wide levels of significance (satisfying the first
instrumental variable assumption), and pruned for LD to
Figure 1. mreggerplot output for applied examples using BMI (A) and height (B) as exposures.
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limit the overlap between SNPs. The IVW estimator also
requires that genetic variants should not have directional
pleiotropic effects. The MR Egger and median estimators are
robust to directional pleiotropy if the effects of the exposure
are constant. MR Egger regression requires the InSIDE as-
sumption, whereas median methods assume that the number
of valid instruments is greater than 50%. For MR-Egger esti-
mation where the value of I2GX is low, it is possible to use
SIMEX to correct for regression attenuation towards the
null. This is implemented using the mreggersimex command.
In this paper, we have presented the mrrobust Stata
package as an accessible toolkit for performing summary
MR and instrumental variable analysis using many instru-
ments. It contains a range of summary MR approaches,
and should make examining causal relationships using
Mendelian randomization more accessible for genetic
epidemiologists.
Supplementary Data
Within the Supplementary material, available at IJE online, we in-
clude example code and Stata output for each of the analyses per-
formed within this paper, as well as the summary data obtained
from the MRBase GWAS catalogue. We also include a brief sum-
mary of the I2GX statistic, as well as guidance on implementing and
interpreting the modal estimator.
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